Core Scientific Upgraded to Outperform, $30 Target
Citizens analyst Greg Miller upgrades Core Scientific to Outperform, citing strong growth, HPC demand, and strategic focus after CoreWeave deal setback.
/ 9 items
#CORZ↓
Core Scientific and CoreWeave Merger Is Off: What Happened?
Core Scientific shareholders rejected the merger with AI company CoreWeave. The deal is terminated, but their business partnership continues.
B. Riley Upgrades Core Scientific as CoreWeave Deal Faces Growing Opposition
B. Riley raises Core Scientific price target to $30, predicting shareholders will vote down CoreWeave's $9B offer. Glass Lewis and ISS recommend voting against.